Naftin
NDC 83107-023, Naftifine Hydrochloride, gel, from Legacy Pharma USA Inc..
- Product NDC
- 83107-023
- Status
- Listed
- Labeler
- Legacy Pharma USA Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204286
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83107-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAFTIFINE HYDROCHLORIDE2 g/100g
Pharmacologic classes
Allylamine Antifungal [EPC]; Allylamine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83107-023-45 | 83107002345 | 1 TUBE in 1 CARTON (83107-023-45) / 45 g in 1 TUBE |
| 83107-023-60 | 83107002360 | 1 TUBE in 1 CARTON (83107-023-60) / 60 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6c6ee055-4031-45a7-8561-ccd989343580
Use it
Look up 83107-023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83107-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83107-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.